Back to
CAPTRUST Financial Advisors
CORT
24 quarters
Position history for
CAPTRUST Financial Advisors's holdings in Corcept Therapeutics Incorporated
Yes. Captrust holds 37,447 shares of CORT (Corcept Therapeutics), worth $3.3M, as of its Q2 2026 13F filing. It increased the position by 13,652 shares (+57.4%) from Q1 2026. Captrust has held CORT since Q3 2020, across 24 quarterly 13F filings.
Current Value
$3.3M
Current Shares
37,447
Total Value Change
+$3.3M
Total Shares Change
+37,327
Quarter-by-Quarter History
Other major holders of CORT: BlackRock, Inc., Vanguard Group Inc.